The association between anti‐insulin aspart antibodies and the pharmacokinetic and pharmacodynamic characteristics of fast‐acting insulin aspart in children and adolescents with type 1 diabetes

BACKGROUND: Fast‐acting insulin aspart (faster aspart) is a novel formulation of insulin aspart (IAsp) ensuring ultrafast absorption and effect. AIM: To compare the pharmacokinetics between faster aspart and IAsp, based on free or total IAsp measurement, and investigate the association between anti‐...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pediatr Diabetes
Päätekijät: Biester, Torben, von dem Berge, Thekla, Bendtsen, Line Quist, Bendtsen, Mette Dahl, Rathor, Naveen, Danne, Thomas, Haahr, Hanne
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons A/S 2020
Aiheet:
Clinical Care and Technology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7383777/
https://ncbi.nlm.nih.gov/pubmed/32306477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pedi.13026
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia